English/中文

Product Site

2018-12-21

PharmaBlock Invests Over 65 Million USD on New Dis...

China, NJ-December 20, 2018- PharmaBlock Sciences (Nanjing), Inc., the leading provider of innovat...

2018-11-26

PharmaBlock Begins Operation of New ProcessR&D Cen...

PharmaBlock (USA), Inc. recently completed renovation of its new processR&D center in Philadelphia S...

2018-09-28

PharmaBlock Acquires a GMP compliantManufacturing ...

-Facility is acquired from Porton PharmaSolutions Ltd., and operated with GMP compliance.-Located in...

2018-09-20

PharmaBlock appoints Dr. ShijieZhang as Chief Tech...

PharmaBlockSciences (Nanjing), Inc. (SZSE: 300725), a global leader in providinginnovative chemistry...

2018-09-11

PharmaBlock to Attend 2018 CPhI Worldwide in Madri...

October 9-11, PharmaBlock will exhibit at the CPhIWorldwide 2018 in Madrid, Spain. We take the priv...

2018-07-02

Dr. Michael Jay Shapiro, Senior Consultant and Vic...

Dr. Michael Jay Shapiro, Senior Consultant and Honorary Vice President of PharmaBlock, has been awar...

2018-08-30

PharmaBlock to Attend 2018 ChemOutsourcing at New ...

PharmaBlock will attend the 2018ChemOutsourcing on September 17-19, in New Jersy, USA. ChemOu...

2018-06-05

【2018 CPhI Invitation】Follow the Molecule, From Di...

PharmaBlock (www.pharmablock.com) will attend CPhI China 2018 to be held in Shanghai during June 20-...

2018-07-23

FDA Grants Approval of TIBSOVO®, the First Ora...

CAMBRIDGE, Mass., July 20, 2018 (GLOBE NEWSWIRE) -- - Approval of TIBSOVO® was Based on Phase 1 ...

2018-04-20

PharmaBlock Attended APRDL 2018 on Invitation to D...

▼ SPOTLIGHTPharmaBlock Sciences (Nanjing), Inc. attended The Asia Pharma R&D Leaders Summit 2018 (AP...